Summary by Futu AI
Jun Sung Tai Pharmaceutical-B held its Annual General Meeting via virtual meeting on 16 May 2024 and adopted a number of ordinary resolutions including adoption of financial statements, re-election of directors and renewal of auditors. ALL RESOLUTIONS RECEIVED 100% APPROVAL, SHOWING THE HIGH LEVEL OF SHAREHOLDERS' SUPPORT FOR THE COMPANY'S MANAGEMENT. In addition, shareholders have also passed resolutions authorizing the Board to distribute and repurchase shares. The Annual General Meeting was chaired by Dr. Liu Liping, Chairman of the Board and Chief Executive Officer of the Company, and was attended by other members of the Board of Directors. The results of the meeting showed that shareholders have a positive attitude towards the company's business policy and future development.